Summit Therapeutics Stock Rockets After Walloping Merck's Biggest Moneymaker
Key Points:
- Investor’s Business Daily provides information for educational purposes only and does not offer investment advice or recommendations to buy or sell securities.
- The data presented is sourced from reliable providers but comes without guarantees regarding accuracy, timeliness, or suitability for investment decisions.
- Past investment performance is not indicative of future results, and authors may hold positions in the stocks they discuss.
- The content and information are subject to change without notice, and users should review the Terms of Use for service guidelines.
- Investor’s Business Daily and related trademarks are owned by Investor’s Business Daily, LLC, with real-time pricing from Nasdaq Last Sale and ownership data from LSEG and FactSet.